
A $55,000 drug that doesn’t cure Alzheimer’s
Today, Explained
The Controversy of Alzheimer's Drug Pricing and Efficacy
This chapter analyzes the controversial pricing and implications of a new Alzheimer's drug that does not offer a cure. It explores the ethical and economic challenges faced by patients and healthcare systems amidst ongoing debates about treatment efficacy.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.